Position in SCLX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$458
-$1,017 QoQ
Shares Held
69
-43.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $16,837,469,618 across 20 Drug Manufacturers - General names. SCLX ranks #18 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
16,925,454 | $4,137,257,974 | |
| 2 | LLY |
ELI LILLY & Co
|
4,405,844 | $4,052,363,133 | |
| 3 | AMGN |
Amgen Inc
|
7,088,010 | $2,493,916,315 | |
| 4 | ABBV |
AbbVie Inc.
|
8,909,597 | $1,937,748,249 | |
| 5 | MRK |
Merck & Co., Inc.
|
11,446,845 | $1,376,940,982 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
6,628,441 | $923,805,819 | |
| 7 | PFE |
Pfizer Inc
|
19,533,309 | $548,495,315 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,946,447 | $360,652,008 |
All Filings in SCLX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $458 | 69 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $1,475 | 121 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,026 | 103 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,530 | 260 | Shares | Defined | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||